Masala C, Amendolea M A, Bonini S
Lancet. 1976 Oct 16;2(7990):821-4. doi: 10.1016/s0140-6736(76)91208-3.
An indirect immunofluorescence technique and an indirect immunoperoxidase technique were used on cryostat sections of human group-O submaxillary salivary gland and rat stomach. Circulating antibodies reacting with mucus antigen(s) were found in sera from 52-7% of patients with active pulmonary tuberculosis and in 21-8% of patients with chronic obstructive lung disease. Among hospital patients with other diseases and healthy controls, mucus antibodies were found in 7-2 and 5.4% respectively. The mucus antibodies were not absorbed by an excess of red blood-cells derived from group AD+ healthy subjects or from the rat donor of the stomach, while the fluorescence and the immunoperoxidase reactions were almost completely abolished after the absorption of positive sera with human dried bronchial secretion. It is postulated that mucus antibody may be a new and important serological marker of disorders accompanied by mucus accumulation in the lung and possibly other organs and/or by severe changes of the anatomical structures which act as a barrier to the reabsorption of abnormal amounts of mucus.
采用间接免疫荧光技术和间接免疫过氧化物酶技术,对人O型颌下唾液腺和大鼠胃的冰冻切片进行检测。在52.7%的活动性肺结核患者血清和21.8%的慢性阻塞性肺疾病患者血清中,发现了与黏液抗原发生反应的循环抗体。在患有其他疾病的住院患者和健康对照者中,黏液抗体的检出率分别为7.2%和5.4%。黏液抗体不会被来自AD+健康受试者的过量红细胞或大鼠胃供体的红细胞所吸收,而在用人类干燥支气管分泌物吸收阳性血清后,荧光和免疫过氧化物酶反应几乎完全消失。据推测,黏液抗体可能是一种新的重要血清学标志物,用于指示伴有肺部及可能其他器官黏液积聚和/或作为异常量黏液重吸收屏障的解剖结构严重改变的疾病。